US HB2009 | 2017-2018 | 115th Congress

Status

Sponsorship: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on April 6 2017 - 25% progression, died in committee
Action: 2017-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Fostering Innovation in Medical Imaging Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve a medical imaging device intended to be used with an approved contrast agent when—under specified conditions—the use differs from the approved use of the contrast agent. (Contrast agents are substances used to enhance the visibility of body structures in medical imaging.) The FDA center that reviews medical devices has primary jurisdiction over such reviews. After authorization of a medical imaging device that makes new use of a contrast agent, the sponsor of the approved contrast agent may submit a supplemental application for the new use of the contrast agent.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Fostering Innovation in Medical Imaging Act of 2017

Sponsors


History

DateChamberAction
2017-04-07HouseReferred to the Subcommittee on Health.
2017-04-06HouseReferred to the House Committee on Energy and Commerce.
2017-04-06HouseIntroduced in House

Subjects


US Congress State Sources


feedback